| What: |
Join Team-In-Training during its 20th anniversary season of saving lives while achieving challenges of a lifetime.
Sign up now at a local information meeting for the upcoming season of the Leukemia and Lymphoma Society's ground-breaking endurance sports training program.
Team-In-Training, a program of the Leukemia and Lymphoma Society, is the world's largest endurance training program.
Since our inception, more than 340,000 participants have raised more than $800 million for life-saving cancer research and to help blood cancer patients live linger, better lives. This year's cumulative goal is $1 billion.
Team-In-Training provides personalized coaching, group training and support to persons interested in participating in marathons and half-marathons.
In return, participants raise funds that go directly to the Leukemia and Lymphoma Society, the world's largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services
An information meeting will be held at 6:30 p.m. Thursday, July 24, at Runner's Lane, 26248 Bouquet Canyon Road, Santa Clarita.
For more information, call
Tim Stafford at 310-846-4731 or e-mail
Tim.Stafford@lls.org.
Since its inception in 1988, when a team of 38 runners trained together for the New York City Marathon and raised $320,000, the Leukemia and Lymphoma Society's Team-In-Training program, has prepared more than 340,000 people -approximately 39,000 participants annually - to achieve their dream of completing a marathon, half marathon, triathlon or 100-mile (century) bicycle ride.
And, in that time, Team-In-Training participants have raised more than $800 million to support blood cancer research and patient services.
The enormous success of this program has helped make possible advances in blood cancer therapies and treatments that have prolonged and enhanced the lives of hundreds of thousands of patients.
The Leukemia and Lymphoma Society, headquartered in White Plains, N.Y., with 68 chapters in the United States and Canada, is the world's largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services.
The society's mission is to cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families.
Since its founding in 1949, the society has invested more than $550 million in research specifically targeting leukemia, lymphoma and myeloma. Last year alone, the society made 5.1 million contacts with patients, caregivers and healthcare professionals through services provided at its home office and by its 63 chapters nationwide.
|